top of page

Currently ongoing clinical trials of PVX108  for Peanut Allergy

Examination of a child
Phase 2 Studies: AVX-201
(currently recruiting)

AVX-201 is a double blind randomised Phase 2 study in adolescents and children with peanut allergy. The aims of the trial are to evaluate the efficacy and safety of PVX108 when administered intradermally in monthly doses over a 12 month period. The AVX-201 trial is being run under an IND and is currently recruiting at clinics in Australia and the United States.

Interested in participating?
Find out more on or contact the trial centre nearest you (details below)


New South Wales

Currently Recruiting

Children's Hospital at Westmead

Westmead, NSW 2145

Currently Recruiting

Sydney Children's Hospital

Randwick, NSW 2031


Recruiting Soon

Queensland Children's Hospital

South Brisbane, QLD 4101

South Australia

Currently Recruiting

Women's and Children's Hospital, Adelaide

North Adelaide, SA 5006


Active, Not Recruiting

Murdoch Children's Research Institute,

Royal Children's Hospital

Melbourne Parkville, VIC 3052

United States


Currently Recruiting

Arkansas Children's Research Institute
Little Rock, Arkansas,


Currently Recruiting

Peninsula Research Associates

Rolling Hills Estates, California, 90274


Currently Recruiting

Children's Healthcare of Atlanta

Atlanta, Georgia, 30329


Currently Recruiting

IAA Clinical Research

Chevy Chase, Maryland, 20815


Currently Recruiting

Massachusetts General Hospital

Boston, Massachusetts, 02114


Recruiting Soon

Riley Children's Hospital at IU

Indianapolis, Indiana, 462020


Currently Recruiting

Johns Hopkins Hospital

Baltimore, Maryland, 21205

North Carolina

Currently Recruiting

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599

Western Australia

Currently Recruiting

Perth Children's Hospital

Nedlands, WA 6009

bottom of page